Existing evidence suggests that olfactory training is a low-risk intervention that provides clinically relevant and sustained benefit in some PISL patients.

Existing evidence suggests that olfactory training is a low-risk intervention that provides clinically relevant and sustained benefit in some PISL patients.
Treatment-seeking transgender women perceive a voice handicap in speaking and singing that appears separate from gender-related voice/communication concerns.
Chemosensory dysfunction is very common in COVID-19 and, although most people regain function within the first 28 days.
Betahistine is widely used in Europe and the rest of the world in the treatment of Ménière’s disease.
Radiofrequency ablation for benign thyroid nodule has recently gained traction among otolaryngologists for patients seeking a nonsurgical treatment option.
Literature review does not support routine use of tomography (CT) prior to planned primary stapedotomy in patients with adult-onset CHL/MHL.
Recurrent respiratory papillomatosis continues to decline since the implementation of the HPV vaccination, and advancements show promise in RRP medical management.
New but limited data have emerged suggesting that oral steroids with olfactory training may be a safe and effective treatment for loss of smell due to COVID-19.
Systemic corticosteroids are the firstline treatment of autoimmune inner ear disease, with intratympanic steroids as a possible adjuvant or alternative.
Although acupuncture is used to treat a variety of medical conditions, there is insufficient evidence to support its use in chronic rhinosinusitis.